Clinical Trials in Atlanta

Showing 19321-19340 of 19,805 trials

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

NCT00002418

The purpose of this study is to see if it is safe and effective to give a new anti-HIV drug combination to HIV-infected patients who have never taken nonnucleoside reverse transcriptase inhibitors (NNRTIs) and who have failed to respond to protease inhibitors (PIs). The drug combination will contain didanosine (ddI) plus stavudine (d4T) plus nevirapine (NVP) plus MKC-442. Hydroxyurea (HU) may be added.

HIV Infections

Bristol-Myers Squibb25 participants

Beverly Hills, California, United States • Denver, Colorado, United States • Atlanta, Georgia, United States +2 more locations

TERMINATEDPhase 3< 1 mile

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

NCT00380276

Open-label treatment with MPC-7869 for participants in a previous randomized study.

Alzheimer's Disease

Myrexis Inc.1,000 participantsStarted Sep 2006

Alabaster, Alabama, United States • Huntsville, Alabama, United States • Phoenix, Arizona, United States +87 more locations

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Find Trials by Condition in Atlanta

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Karenitecin in Treating Patients With Recurrent Malignant Glioma

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

GORE-TEX PROPATEN Vascular Graft Study

A Blood Test to Look at Cells of the Immune System in Healthy Children

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

Biomarkers in Acute Heart Failure

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis